← Open Payments lookup

VALERIE ARCHER: Open Payments

NPI 1881240216 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,534 in 109 payments from 16 companies in 2025. Trend: 2023 $1,177 · 2024 $1,924 · 2025 $2,534

Food & beverage: $2,430Education: $104
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.23$461
Otsuka America Pharmaceutical, Inc.26$438
Neurocrine BioSciences, Inc.10$366
Alkermes, Inc.13$350
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)11$241
ABBVIE INC.7$221
Teva Pharmaceuticals USA, Inc.5$183
Janssen Pharmaceuticals, Inc3$78
ACADIA Pharmaceuticals Inc2$38
Bausch Health US, LLC2$38

Products named: COBENFY, REXULTI, INGREZZA, ARISTADA, CAPLYTA, VRAYLAR, SPRAVATO, AUSTEDO XR.

Industry payments across NV — which companies pay providers there.